Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02512926
Title Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phoenix Children's Hospital
Indications

leukemia

Therapies

Cyclophosphamide

Carfilzomib

Etoposide

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.